Real-time enrollment status for this prostate cancer metastatic clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 9:42 AM UTC
| NCT Number | NCT05242744 |
| Recruiting Status | Recruiting |
| Condition | Prostate Cancer Metastatic |
| Phase | Clinical Trial |
| Target Enrollment | 30 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Abramson Cancer Center at Penn Medicine |
| Last Updated on CT.gov | June 26, 2026 (3 weeks ago) |
As of July 18, 2026: Clinical trial NCT05242744 is currently recruiting participants. This clinical trial study for prostate cancer metastatic is actively seeking new participants at 1 location across the United States. The study is sponsored by Abramson Cancer Center at Penn Medicine. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05242744 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05242744 was last updated 3 weeks ago (June 26, 2026). HelloStudys verifies this status automatically.